What are adaptogens? Top blends for stress, focus and more
Article content
For centuries, humans have turned to nature for healing, and one of the wise allies we can lean on is adaptogens — earthy, often bitter botanicals with balancing powers that help us adapt, recalibrate and rise above stress, both emotional and physical.
Article content
When we experience a stressful event, consuming adaptogens can help our bodies return to a state of balance known as homeostasis. These plants and herbs, such as ashwagandha, rhodiola rosea and schisandra are also believed to improve overall energy, vitality, athletic performance and strengthen the immune system.
Article content
Article content
This isn't new-age fluff. It's basic biology. It's the kind of ancient partnership that reminds us we're not machines that need fixing — we're ecosystems that, like nature, require tending.
Article content
All adaptogens help the body resist the effects of stress, but each offers unique support based on your specific needs.
Article content
Article content
For mental clarity, focus and energy: Lion's mane and chaga are top contenders — both are revered mushrooms rich in antioxidants and neuro-protective compounds. You'll often find them in instant coffee blends, coffee creamers or daily drink mixes.
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBC
an hour ago
- CBC
RFK Jr. cancels $500M US in funding for vaccine development, targeting mRNA
The U.S. Department of Health and Human Services will cancel contracts and pull funding for some vaccines that are being developed to fight respiratory viruses like COVID-19 and the flu. Robert F. Kennedy Jr. announced in a statement Tuesday that 22 projects, totalling $500 million US, to develop vaccines using mRNA technology will be halted. Kennedy's decision to terminate the projects is the latest in a string that have seen the longtime vaccine critic's agenda overriding scientific criteria at the nation's health department. Kennedy has pulled back recommendations around the COVID-19 shots, fired the panel that makes vaccine recommendations, and refused to offer a vigorous endorsement of vaccinations as a measles outbreak worsened. The health secretary criticized mRNA vaccines in a video on his social media accounts, explaining the decision to cancel projects being led by the nation's leading pharmaceutical companies, including Pfizer and Moderna, that offer protection against viruses like the flu, COVID-19 and H5N1. "To replace the troubled mRNA programs, we're prioritizing the development of safer, broader vaccine strategies, like whole-virus vaccines and novel platforms that don't collapse when viruses mutate," Kennedy said in the video. Infectious disease experts say the mRNA technology used in vaccines is safe, and they credit its development during the first Trump administration with slowing the 2020 coronavirus pandemic. Future pandemics, they warned, will be harder to stop without the help of mRNA. 'Dangerous decision' "I don't think I've seen a more dangerous decision in public health in my 50 years in the business," said Mike Osterholm, a University of Minnesota expert on infectious diseases and pandemic preparations. He noted the technology offers potential advantages of rapid production, crucial in the event of a new pandemic that requires a new vaccine. The shelving of the mRNA projects is short-sighted as concerns about a bird flu pandemic continue to loom, said Dr. Paul Offit, a vaccine expert at Children's Hospital of Philadelphia. "It's certainly saved millions of lives," Offit said of the existing mRNA vaccines. Scientists are using mRNA for more than infectious disease vaccines, with researchers around the world exploring its use for cancer immunotherapies. At the White House earlier this year, billionaire tech entrepreneur Larry Ellison praised mRNA for its potential to treat cancer. Traditionally, vaccines have required growing pieces of viruses, often in chicken eggs or giant vats of cells, then purifying that material. The mRNA approach starts with a snippet of genetic code that carries instructions for making proteins. Scientists pick the protein to target, inject that blueprint and the body makes just enough to trigger immune protection — producing its own vaccine dose. In a statement Tuesday, HHS said "other uses of mRNA technology within the department are not impacted by this announcement." The abandoned mRNA projects signal a "shift in vaccine development priorities," the health department said in its statement, adding that it will start "investing in better solutions." No details were provided on what those other technologies might be.
CTV News
3 hours ago
- CTV News
RFK Jr. pulls US$500 million in funding for vaccine development
Health and Human Services Secretary Robert F. Kennedy Jr. speaks as President Donald Trump listens at an event to promote his proposal to improve Americans' access to their medical records in the East Room of the White House, Wednesday, July 30, 2025, in Washington. (AP Photo/Mark Schiefelbein) WASHINGTON — The U.S. Department of Health and Human Services will cancel contracts and pull funding for some vaccines that are being developed to fight respiratory viruses like COVID-19 and the flu. Robert F. Kennedy Jr., the health secretary and a longtime vaccine critic, announced in a statement Tuesday that US$500 million worth of vaccine development projects, all using mRNA technology, will be halted. The projects — 22 of them — are being led by some of the nation's leading pharmaceutical companies like Pfizer and Moderna to prevent flu, COVID-19 and H5N1 infections. The mRNA vaccines are credited with slowing the 2020 coronavirus pandemic. Kennedy said in the Tuesday statement that he wants the health department to move away from mRNA vaccines, calling on the department to start 'investing in better solutions.' He provided no details on what those technologies might be. Amanda Seitz, The Associated Press
CTV News
4 hours ago
- CTV News
Legionnaires' disease outbreak in New York City grows to 58 illnesses, 2 deaths
Legionella bacteria, seen here under a microscope, cause the respiratory illness known as Legionnaires' disease. (Francis Chandler/CDC/AP via CNN Newsource) Fifty-eight people in New York City have been diagnosed with Legionnaires' disease, a serious bacterial lung infection, and two people have died, according to the city health department. The bacteria, Legionella, is suspected to be spread by cooling towers on buildings in Central Harlem. A cooling tower is a rooftop device that releases mist into the air as it cools a large building. If the water inside becomes too warm, stagnant, or isn't properly disinfected, Legionella can grow and sicken people who inhale the mist. The disease cannot be spread from person to person. The city health department first announced the cluster on July 25. The city said it would test all the cooling towers in the area, and as of Monday, remediation was completed on 11 that had an initial positive screening for the Legionella pneumophila bacteria. 'Anyone in these zip codes with flu-like symptoms should contact a health care provider as soon as possible,' Acting Health Commissioner Dr. Michelle Morse said in a news release on Monday. Legionnaires' disease causes flu-like symptoms, including cough, fever, headaches, muscles aches and shortness of breath. It's treatable with antibiotics, but if left untreated, it can cause shock and multi-organ failure, according to the World Health Organization. About 10 per cent of people who get Legionnaires' die from complications of their illness, according to the U.S. Centers for Disease Control and Prevention, and it's more dangerous for older adults and people with weakened immune systems. Around 6,000 Legionnaires' disease cases are reported each year in the United States, according to the Occupational Safety and Health Administration, but reported totals may be lower than the actual cases in part because it can be difficult to distinguish Legionnaires' disease from other types of pneumonia. By Jeffrey Kopp, CNN
